Entera Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Entera Bio
ENTX Stock  USD 1.60  0.14  8.05%   
Entera Bio's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Entera Bio's valuation are provided below:
Market Capitalization
73.4 M
Enterprise Value Revenue
576.0371
Revenue
124 K
Earnings Share
(0.24)
Quarterly Revenue Growth
(0.92)
We have found one hundred twenty available fundamental signals for Entera Bio, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to verify all of Entera Bio prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. Market Cap is likely to drop to about 50 M in 2026. Enterprise Value is likely to drop to about 41.6 M in 2026

Entera Bio Total Revenue

220,110

Check Entera Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Entera Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 92.6 K, Interest Expense of 31.4 M or Selling General Administrative of 5.2 M, as well as many indicators such as Price To Sales Ratio of 417, Dividend Yield of 0.0 or PTB Ratio of 9.34. Entera financial statements analysis is a perfect complement when working with Entera Bio Valuation or Volatility modules.
  
Build AI portfolio with Entera Stock
Check out the analysis of Entera Bio Correlation against competitors.
For more information on how to buy Entera Stock please use our How to Invest in Entera Bio guide.

Entera Bio Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets13.5 M10.8 M9.4 M
Slightly volatile
Short and Long Term Debt Total232.6 K244.8 K4.1 M
Slightly volatile
Other Current Liabilities1.6 M1 M1.1 M
Slightly volatile
Total Current Liabilities1 M1.1 M2 M
Very volatile
Other Liabilities35 K36.8 K48 K
Pretty Stable
Property Plant And Equipment Net362.4 K381.8 K294.4 K
Slightly volatile
Accounts Payable189.5 K118.8 K260.7 K
Slightly volatile
Cash11.6 M10 M7.8 M
Slightly volatile
Non Current Assets Total558.2 K376.2 K714.6 K
Slightly volatile
Long Term Debt3.3 M3.5 M10 M
Slightly volatile
Cash And Short Term Investments12 M10 M8.1 M
Slightly volatile
Common Stock Shares Outstanding21.9 M43.3 M19.1 M
Slightly volatile
Liabilities And Stockholders Equity13.5 M10.8 M9.4 M
Slightly volatile
Non Current Liabilities Total114.6 K120.6 K13.7 M
Slightly volatile
Other Current Assets159 K167.4 K472.1 K
Slightly volatile
Other Stockholder Equity70.2 M140.3 M50.6 M
Slightly volatile
Total Liabilities1.1 M1.2 M15.7 M
Slightly volatile
Property Plant And Equipment Gross360.5 K381.8 K293.2 K
Slightly volatile
Short and Long Term Debt25.1 M43 M29.6 M
Slightly volatile
Total Current Assets12.7 M10.3 M8.7 M
Slightly volatile
Accumulated Other Comprehensive Income35.1 K36.9 K3.1 M
Very volatile
Short Term Debt145.3 K153 K10.3 M
Slightly volatile
Intangible Assets509.7 K544.5 K621.6 K
Slightly volatile
Property Plant Equipment337.8 K263.4 K263.6 K
Slightly volatile
Non Current Liabilities Other108.8 K58.5 K153.1 K
Slightly volatile
Net Working Capital9 M7 M10.5 M
Very volatile
Current Deferred Revenue36.8 K38.7 K157 K
Slightly volatile
Capital Surpluse61.9 M72.9 M56.3 M
Slightly volatile
Other Assets41.9 K44.1 K540.8 K
Slightly volatile
Long Term Debt Total97.6 K109.8 K119.8 K
Slightly volatile
Capital Lease Obligations238.1 K244.8 K291.8 K
Pretty Stable
Common Stock8559007 M
Slightly volatile

Entera Bio Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization92.6 K52.9 K66.3 K
Slightly volatile
Selling General Administrative5.2 M5.9 M3.9 M
Slightly volatile
Other Operating Expenses11 M11.2 M8.3 M
Slightly volatile
Research Development5.6 M5.2 M4.3 M
Slightly volatile
Total Operating Expenses10.8 M11 M8.2 M
Slightly volatile
Reconciled Depreciation78.2 K41.4 K70.7 K
Pretty Stable
Interest Income696.3 K854.5 K630.3 K
Slightly volatile

Entera Bio Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Sale Purchase Of Stock10.2 M14.7 M8.8 M
Slightly volatile
Stock Based Compensation2.1 M2.9 M1.5 M
Slightly volatile
Begin Period Cash Flow10.7 M12.7 M7.2 M
Slightly volatile
Depreciation74.8 K52.9 K55.7 K
Slightly volatile
Capital Expenditures2.6 K2.7 K39.2 K
Slightly volatile
Total Cash From Financing Activities6.8 M4 M7 M
Pretty Stable
End Period Cash Flow11.6 M10.1 M7.8 M
Slightly volatile
Issuance Of Capital Stock5.9 M3.6 M8.1 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio417397163
Slightly volatile
Days Sales Outstanding440292432
Slightly volatile
Stock Based Compensation To Revenue13.3412.716.1922
Slightly volatile
Capex To Depreciation0.07120.0751.0095
Slightly volatile
EV To Sales373355132
Slightly volatile
Inventory Turnover2.212.492.7146
Slightly volatile
Days Of Inventory On Hand106119130
Slightly volatile
Payables Turnover1.141.170.9541
Slightly volatile
Sales General And Administrative To Revenue17.2625.3314.4526
Slightly volatile
Research And Ddevelopement To Revenue19.3922.3720.49
Slightly volatile
Capex To Revenue0.01810.01910.117
Slightly volatile
Cash Per Share0.250.260.4525
Pretty Stable
Days Payables Outstanding3063222.1 K
Slightly volatile
Income Quality1.090.820.9347
Very volatile
Intangibles To Total Assets0.09810.06780.1251
Slightly volatile
Current Ratio4.626.874.7667
Slightly volatile
Receivables Turnover1.081.291.0232
Slightly volatile
Capex Per Share1.0E-41.0E-40.0031
Slightly volatile
Revenue Per Share0.00530.00550.0283
Slightly volatile
Interest Debt Per Share0.00790.00830.3749
Slightly volatile
Debt To Assets0.03160.03331.2028
Slightly volatile
Operating Cycle469292441
Slightly volatile
Days Of Payables Outstanding3063222.1 K
Slightly volatile
Quick Ratio4.616.874.7608
Slightly volatile
Net Income Per E B T1.11.151.02
Slightly volatile
Cash Ratio4.196.634.1571
Slightly volatile
Days Of Inventory Outstanding106119130
Slightly volatile
Days Of Sales Outstanding440292432
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.111.151.0236
Slightly volatile
Fixed Asset Turnover0.60.631.6018
Slightly volatile
Debt Ratio0.03160.03331.2028
Slightly volatile
Price Sales Ratio417397163
Slightly volatile
Asset Turnover0.02540.02220.0297
Slightly volatile
Gross Profit Margin0.05430.05720.1372
Very volatile

Entera Bio Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap50 M91.8 M57.1 M
Slightly volatile
Enterprise Value41.6 M82.1 M53.5 M
Slightly volatile

Entera Fundamental Market Drivers

Entera Upcoming Events

29th of March 2024
Upcoming Quarterly Report
View
3rd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
29th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Entera Bio Financial Statements

Entera Bio investors use historical fundamental indicators, such as Entera Bio's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Entera Bio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue38.7 K36.8 K
Total Revenue208.2 K220.1 K
Cost Of Revenue197.8 K161.2 K
Stock Based Compensation To Revenue 12.71  13.34 
Sales General And Administrative To Revenue 25.33  17.26 
Research And Ddevelopement To Revenue 22.37  19.39 
Capex To Revenue 0.02  0.02 
Revenue Per Share 0.01  0.01 
Ebit Per Revenue(60.90)(63.94)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
GOOGAlphabet Inc Class C
VVisa Class A
MSFTMicrosoft

Additional Tools for Entera Stock Analysis

When running Entera Bio's price analysis, check to measure Entera Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entera Bio is operating at the current time. Most of Entera Bio's value examination focuses on studying past and present price action to predict the probability of Entera Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entera Bio's price. Additionally, you may evaluate how the addition of Entera Bio to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY